Chinook Therapeutics Inc (NASDAQ:KDNY)

21.88
BATS BZX Real-Time Price
As of 11:27am ET
 +0.89 / +4.24%
Today’s Change
10.48
Today|||52-Week Range
22.05
+34.15%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Chinook Therapeutics Inc have a median target of 32.50, with a high estimate of 48.00 and a low estimate of 20.00. The median estimate represents a +48.54% increase from the last price of 21.88.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Chinook Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.63
Sales
$466.7K
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.04%
 
 
 
 
 
 
Growthannually -9.13%
 
 
 
 
 
 

Sales

Growthquarterly 11.64%
 
 
 
 
 
 
Growthannually -92.27%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.